At its 2026 Annual Meeting of Shareholders held on June 18, 2026, STAAR Surgical Company shareholders approved Amendment No. 2 to the Amended and Restated Omnibus Equity Incentive Plan, increasing the number of common shares reserved for issuance by 3.9 million shares. Shareholders also elected seven directors, ratified BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending January 1, 2027, and approved executive compensation on an advisory basis. The company operates in the medical device industry, specializing in implantable lenses for vision correction.
